Register
Medicines reference
Product

PROPANTELM

Pyrantel + Oxantel + Praziquantel · Fatro S.p.A.

1 form: tablet. In force in Georgia: 1 of 1 (veterinary register).

Forms and doses1 of 1 in force in Georgia

The dose from the product's label, by species and weight. Check the label of the pack you use.

Form Species Dose Frequency Georgia
Tablet · Dog Dog 1 tablet per 10 kg
Give directly by mouth or mixed with food; fasting is not required. Treat on the basis of parasitological diagnosis and investigate suspected anthelmintic resistance. Do not use in hypersensitivity or during lactation; the label permits use during pregnancy. Do not combine with levamisole, piperazine or cholinesterase inhibitors. Vomiting, diarrhoea or anorexia may occur. The official product information does not authorise tablet subdivision, so a non-whole calculated result is not a deliverable dose.
· single administration; repeat after 20 days is advised when indicated
single administration; repeat after 20 days is advised when indicated Georgia Yes, veterinary
Veterinary (National Food Agency)
In the register: პროპანტელმი
№ 165-11
Verified on: 23 Oct 2026
Details: pack, label wording, sources, registration

PROPANTELM, Tablet

Pyrantel 49.618 mg + oxantel 194.223 mg + praziquantel 50 mg tablets for dogs
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog
7.6/10
Good
vetman assessment

PROPANTELM

Pyrantel 49.618 mg + oxantel 194.223 mg + praziquantel 50 mg tablets for dogs
Assessed clinical scopeDog · Complete authorised scope: single-dose oral treatment of the named canine cestodes, whipworm, ascarids and hookworms after parasite/risk assessment · By mouth
Care settingVeterinary-directed treatment with accurate weighing, parasite/risk assessment, reinfection control and response testing when persistence or resistance is plausible
vetman score 7.6/10 Good
Evidence confidence: Medium Georgia: Yes, veterinary · № 165-11 · Verified on 23 Oct 2026

A good, well-supported broad-spectrum canine treatment when the named parasite and a deliverable whole-tablet dose are confirmed. Strong efficacy and single-dose convenience are tempered by coarse 10 kg dose fit, no authorised splitting, stage/reinfection limits, resistance stewardship and incomplete exact-product overdose evidence.

Regulatory and scientific credibility8.5/10

Exact identity, composition, dose and restrictions are transparent in current Georgian and EU regulatory records. Direct combination field evidence and official cross-jurisdiction controls are available; confidence stops below high because the public exact text is old and a modern exact-brand assessment/outcome dossier was not found.

Clinical efficacy8.5/10

A 235-dog European efficacy population showed approximately 97.2-100% day-7/14/21 control across the principal labelled nematode and cestode endpoints. The complementary mechanisms fit the full spectrum, but benefit remains parasite- and stage-specific: arrested hookworm larvae, reinfection, missed intermediate hosts and resistance can defeat an apparently correct treatment.

Safety and tolerability7.0/10

The combination is generally well tolerated and supportive FDA pyrantel/praziquantel data show a useful safety margin. Vomiting, diarrhoea and anorexia remain expected signals; bloody diarrhoea/lethargy occurred rarely in comparator field data. Lactation is prohibited, important cholinergic interactions apply and exact-product overdose data are absent.

Clinical practicality5.5/10

One oral dose, no fasting and optional food mixing are convenient. The exact label nevertheless authorises one tablet per 10 kg without confirming subdivision, so many small or intermediate-weight dogs lack a deliverable exact dose; accurate weighing, alternative-strength selection, parasite-specific follow-up and environmental/intermediate-host control remain clinical work.

Full-course cost-effectiveness-

Current Georgian treatment price was unavailable; price is excluded from the denominator.

Important safety and use flags

  • Scope boundary: this score covers the complete labelled treatment spectrum in dogs—named cestodes, whipworm, ascarids and hookworms. It does not establish prevention of every worm, heartworm/lungworm/protozoal efficacy, or use in cats or another species.
  • Diagnose and risk-assess: identify the likely parasite with faecal testing, visible segments, epidemiology and exposure as appropriate. Severe hookworm anaemia requires stabilization/supportive care; suspected Echinococcus needs public-health and jurisdiction-specific handling.
  • Exact dose: accurately weigh and give one whole tablet/10 kg once PO (pyrantel 5, oxantel 20 and praziquantel 5 mg/kg), directly or with food; fasting is unnecessary. Do not transfer another strength, salt quantity or product weight table.
  • No authorised splitting: the exact official information does not confirm tablet subdivision. A fractional calculation is not a deliverable dose—do not round up/down or crush; select a suitable authorised strength/presentation, especially below 10 kg or between 10 kg steps.
  • Repeat boundary: the label advises a repeat after 20 days for larvae present at initial treatment, but this is not an automatic indefinite 20-day or monthly prevention schedule. Tailor repeat timing to parasite biology, diagnosis, exposure and current local guidance.
  • Control reinfection: remove faeces promptly, treat relevant in-contact animals as indicated, control fleas for Dipylidium and address prey/raw-offal access for Taenia/Echinococcus. Environmental eggs/larvae may remain viable for months or years.
  • Resistance/failure: persistent eggs or signs require adherence, reinfection, parasite identity and quantitative pre/post-treatment assessment. Pyrantel-resistant and multidrug-resistant Ancylostoma occurs; use a different class/plan only from a documented veterinary work-up.
  • Safety: stop and reassess significant or persistent vomiting, diarrhoea, bloody stool, anorexia, lethargy or hypersensitivity. The exact label has no overdose data; severe parasite disease itself may worsen anaemia or GI signs despite worm killing.
  • Do not use during lactation or with levamisole, piperazine or a cholinesterase inhibitor. The label permits pregnancy, but confirm the intended patient and avoid unsourced extrapolation to nursing dams, very young puppies or non-target species.
  • Handler/product safety: wash hands after contact, avoid use by people hypersensitive to an active, do not ingest, keep away from children and seek medical advice after accidental ingestion. Keep in the original blister and discard according to local requirements.
Assessment sources
Assessed: 23 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Pyrantel49.618 mg Oxantel194.223 mg Praziquantel50 mg
Formulation Type
Tablet
Administration route
By mouth
Manufacturer
Fatro S.p.A. · Italy
Registration
Georgia Yes, veterinary
Veterinary (National Food Agency)
In the register: პროპანტელმი
№ 165-11
Verified on: 23 Oct 2026
EU Yes, veterinary
№ 104079013/025/037/049/052/064/076/088
Verified on: 23 Oct 2026
UK No
US No
Controlled in Georgia
Unknown
Information not fully verified Whole-label treatment scope: diagnosed canine cestodes, whipworm, ascarids and hookworms named in the product information. Give one whole tablet/10 kg once PO, directly or mixed with food; fasting is unnecessary. Repeat after 20 days only when indicated by the parasite/life-cycle plan. The exact label does not authorise tablet subdivision, so a fractional result must trigger selection of a suitable presentation rather than rounding.
DoseSpeciesWeightRouteFrequencySource
1 tablet per 10 kg
Give directly by mouth or mixed with food; fasting is not required. Treat on the basis of parasitological diagnosis and investigate suspected anthelmintic resistance. Do not use in hypersensitivity or during lactation; the label permits use during pregnancy. Do not combine with levamisole, piperazine or cholinesterase inhibitors. Vomiting, diarrhoea or anorexia may occur. The official product information does not authorise tablet subdivision, so a non-whole calculated result is not a deliverable dose.
Dog Any weight By mouth single administration; repeat after 20 days is advised when indicated
EU SPC 2022
Official product label (SPC)
Approved by a medicines regulator as part of the product's authorisation. It applies to that product as authorised there.
PROPANTELM tablets for dogs - Official Product Information
EU Veterinary Medicines Information, 2022
Active substance doses, with sources
Active substance Pyrantel
Dose calculatorCalculates the active-substance amount; it is not a prescription.
PatientSpecies and weight will be filled in automatically in other calculators.
Selected dose
Dose Species Indication Route Frequency Source
14.4 mg/kg Dog Maintenance By mouth once
VMD SPC 2022
Official product label (SPC), VMD, UK
Approved by the UK Veterinary Medicines Directorate (VMD) as part of the product's authorisation. It applies to that product as authorised there.
Krka Multiwormer 50/144/150 mg tablets for dogs - Summary of Product Characteristics
UK Veterinary Medicines Directorate, 2022
20 mg/kg Cat Maintenance By mouth once
VMD SPC 2024
Official product label (SPC), VMD, UK
Approved by the UK Veterinary Medicines Directorate (VMD) as part of the product's authorisation. It applies to that product as authorised there.
Krka Wormer 230 mg/20 mg film-coated tablets for cats - Summary of Product Characteristics
UK Veterinary Medicines Directorate, 2024
Active substance Praziquantel
Dose calculatorCalculates the active-substance amount; it is not a prescription.
PatientSpecies and weight will be filled in automatically in other calculators.
Selected dose
Dose Species Indication Route Frequency Source
5 mg/kg Dog, Cat Maintenance By mouth once
VMD SPC 2022
Official product label (SPC), VMD, UK
Approved by the UK Veterinary Medicines Directorate (VMD) as part of the product's authorisation. It applies to that product as authorised there.
Krka Multiwormer 50/144/150 mg tablets for dogs - Summary of Product Characteristics
UK Veterinary Medicines Directorate, 2022
VMD SPC 2024
Official product label (SPC), VMD, UK
Approved by the UK Veterinary Medicines Directorate (VMD) as part of the product's authorisation. It applies to that product as authorised there.
Krka Wormer 230 mg/20 mg film-coated tablets for cats - Summary of Product Characteristics
UK Veterinary Medicines Directorate, 2024

Oxantel: No dose supported by a publicly verifiable source yet

Known Contraindications

  • Critical Praziquantel
    Do not use in cases of known hypersensitivity to the active substances or to any of the excipients.
    Sources: VMD SPC · VMD
  • Critical Pyrantel (Dog)
    Do not use in dogs younger than 2 weeks of age and/or weighing less than 2 kg.
    Sources: VMD SPC · VMD · FDA

All of this shows in vetman as you prescribe

The dose for the patient's weight, registration in Georgia and controlled status, right on the prescription.